Purple Biotech

About

Funding history · 17 rounds · $10.0M total

Headcount over time

Q&A

What is Purple Biotech's primary focus?

Purple Biotech is a clinical-stage biotechnology company dedicated to developing first-in-class therapies to overcome tumor immune evasion and drug resistance for cancer patients.

When was Purple Biotech founded and where is it headquartered?

Purple Biotech was founded in August 1968 and is headquartered in Rehovot, Israel.

What was Purple Biotech formerly known as?

Purple Biotech was formerly known as Kitov Pharma Ltd. and changed its name in December 2020.

What is the most recent funding round for Purple Biotech?

Purple Biotech completed a Public Offering in December 2024, raising $2.8 million.

What is Purple Biotech's total funding raised to date?

Purple Biotech has raised a total of $84.34 million across all funding rounds.

How many employees does Purple Biotech currently have?

Purple Biotech has 1-10 employees.

What is the most recent acquisition made by Purple Biotech?

In February 2023, Purple Biotech acquired Immunorizon for $100 million.

Who is the CEO of Purple Biotech?

Gil Efron serves as the Chief Executive Officer of Purple Biotech.

Team · 14

John Paul Waymack

Founder · Founder

Gil Efron

Chief Executive Officer

LinkedIn ↗

Shai Lankry

Chief Financial Officer

LinkedIn ↗

Michael Schickler

Head of Clinical and Regulatory Affairs

Eric Rowinsky

Chairman of the Board

Isaac Israel

Board Member

Simcha Rock

Board Member

Ido Agmon

Board Member

Robert Gagnon

Board Member

Suzana Nahum-Zilberberg

Board Member

Yael Margolin

Board Member

Eyal Gottlieb

Scientific Advisory Board

Steven Maron

Scientific Advisory Board

Sunil Sharma

Scientific Advisory Board

Sectors & technology

Highlights

Tags